INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 421s ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
MS
Corporate insider

Montecalvo Antonio S.

Vice President, Health PolicyCIK 0001759261

EDGAR filingsOpen in network
Disclosed transactions8
Buys / sells0 / 0
Max Insider Score19
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
MS
Montecalvo Antonio S.Vice President, Health Policy
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
40.6K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Organogenesis Holdings Inc.Vice President, Health Policy · Feb 18, 2026
13
MS
Montecalvo Antonio S.Vice President, Health Policy
ORGOOrganogenesis Holdings Inc.
Grant or award
A
—
11.2K sh
Feb 18, 2026
Feb 20, 2026
traded Feb 18, 2026
+2d
SEC FORM 4

Evidence

9
MS
Montecalvo Antonio S.Vice President, Health Policy
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$14K
3,741 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

9
MS
Montecalvo Antonio S.Vice President, Health Policy
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
23.2K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

15
MS
Montecalvo Antonio S.Vice President, Health Policy
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$5,181
1,389 sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

19
MS
Montecalvo Antonio S.Vice President, Health Policy
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$36K
9,607 sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

15
MS
Montecalvo Antonio S.Vice President, Health Policy
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$15K
4,100 sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

15
MS
Montecalvo Antonio S.Vice President, Health Policy
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$13K
3,523 sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence